TI
ORMP icon

Trexquant Investment’s Oramed Pharmaceuticals ORMP Stock Holding History

Trexquant Investment’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,088
Closed -$173K – 1623
2021
Q4 		$173K Buy
12,088
+964
+9% +$20.2K 0.01% 1177
2021
Q3 		$245K Buy
+11,124
New +$189K 0.02% 861

Other funds holding ORMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Trexquant Investment's ORMP Position: Q1 2022 in Review

Trexquant Investment sold out of Oramed Pharmaceuticals (ORMP) in Q1 2022, closing a stake of 12,088 shares — an estimated $173K sold.

Trexquant Investment first reported a position in ORMP in Q3 2021 and held it in 2 quarters. The position peaked at $245K in Q3 2021. 103 funds tracked by Wall St. Rank hold ORMP as of Q1 2022.

  • Trexquant Investment reported no remaining Oramed Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 12,088 Oramed Pharmaceuticals shares in Q1 2022, an estimated $173K.
  • Trexquant Investment first reported a position in Oramed Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Trexquant Investment's Oramed Pharmaceuticals position peaked at $245K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.